H Harvey

1.0k total citations
18 papers, 840 citations indexed

About

H Harvey is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, H Harvey has authored 18 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Genetics. Recurrent topics in H Harvey's work include Estrogen and related hormone effects (4 papers), HER2/EGFR in Cancer Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). H Harvey is often cited by papers focused on Estrogen and related hormone effects (4 papers), HER2/EGFR in Cancer Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). H Harvey collaborates with scholars based in United States, India and Canada. H Harvey's co-authors include Allan Lipton, Kim Leitzel, Y A Teramoto, Laurence M. Demers, L. Demers, A. Lipton, V. M. Chinchilli, Kerstin Konrad, Howard Grossberg and R. Sack and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

H Harvey

17 papers receiving 808 citations

Peers

H Harvey

ONCOL

RNMI

GENET

Allen M. Vukov United States

Yoshio Tanji Japan

Kathy Chun Canada

J. L. Formento France

Daniele Andreis Italy

A Demaille France

Frédéric Commo France

Philip E. Lammers United States

Po‐Han Lin Taiwan

Florence Mishellany France

Allen M. Vukov United States

H Harvey

511 ×1.0

ONCOL

62 ×0.2

RNMI

101 ×0.5

118 ×0.7

GENET

145 ×1.2

Citations per year, relative to H Harvey H Harvey (= 1×) peers Allen M. Vukov

Countries citing papers authored by H Harvey

Since Specialization

Citations

This map shows the geographic impact of H Harvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Harvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Harvey more than expected).

Fields of papers citing papers by H Harvey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Harvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Harvey. The network helps show where H Harvey may publish in the future.

Co-authorship network of co-authors of H Harvey

This figure shows the co-authorship network connecting the top 25 collaborators of H Harvey. A scholar is included among the top collaborators of H Harvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Harvey. H Harvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Cheng, Yan, Shan Yu, Zhang Li, et al.. (2016). eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis. Oncogene. 35(49). 6293–6308. 37 indexed citations

Somlo, George, Paul Frankel, X. Cynthia, et al.. (2013). Abstract P2-16-05: Efficacy of ABT-888 (veliparib) in patients with BRCA-associated breast cancer. Cancer Research. 73(24_Supplement). P2–16.

Kerr, Stephen J., et al.. (2005). Phase II trial of gemcitabine and irinotecan plus celecoxib in advanced adenocarcinoma of the pancreas. Journal of Clinical Oncology. 23(16_suppl). 4155–4155. 8 indexed citations

Makhoul, Issam, et al.. (2004). Effect of aromatase inhibitor therapy on cognitive function. Journal of Clinical Oncology. 22(14_suppl). 846–846. 1 indexed citations

Ali, Suhail M., Francisco J. Esteva, G. N. Hortobagyi, et al.. (2001). Safety and Efficacy of Bisphosphonates Beyond 24 Months in Cancer Patients. Journal of Clinical Oncology. 19(14). 3434–3437. 70 indexed citations

Leitzel, Kim, Y A Teramoto, Kerstin Konrad, et al.. (1995). Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.. Journal of Clinical Oncology. 13(5). 1129–1135. 247 indexed citations

Lipton, Allan, Laurence M. Demers, Christopher Hamilton, et al.. (1993). Increased urinary excretion of pyridinium cross-links in cancer patients. Clinical Chemistry. 39(4). 614–618. 47 indexed citations

Leitzel, Kim, Y A Teramoto, Beatrice Langton-Webster, et al.. (1992). Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients.. Journal of Clinical Oncology. 10(9). 1436–1443. 110 indexed citations

Dickson, D. Howard & H Harvey. (1992). Myeloid body development in the chick retinal pigment epithelium. Current Eye Research. 11(2). 147–152. 7 indexed citations

10.

Miele, Monica, E.S. Vesell, W. Christopher Ehmann, et al.. (1992). Hormonal and immunological regulation of 2′,5′-oligoadenylate synthetase activity in human peripheral blood mononuclear cells. Clinical Immunology and Immunopathology. 65(2). 183–192. 3 indexed citations

11.

Lipton, Allan, H Harvey, Kate Hopper, et al.. (1990). Phase I study of interleukin-2 and interferon alfa-2a as outpatient therapy for patients with advanced malignancy.. Journal of Clinical Oncology. 8(10). 1657–1663. 57 indexed citations

12.

Santen, Richard J., Laurence M. Demers, Herman Adlercreutz, et al.. (1989). Inhibition of Aromatase With CGS 16949A in Postmenopausal Women*. The Journal of Clinical Endocrinology & Metabolism. 68(1). 99–106. 89 indexed citations

13.

Sack, R., H Harvey, & Itaciara Larroza Nunes. (1989). Disinfection associated spoilage of high water content ionic matrix hydrogels.. PubMed. 15(2). 138–45. 1 indexed citations

14.

Sack, R., et al.. (1987). Specificity and biological activity of the protein deposited on the hydrogel surface. Relationship of polymer structure to biofilm formation.. PubMed. 28(5). 842–9. 100 indexed citations

15.

Santen, Richard J., Alice E. Boucher, Steven J. Santner, et al.. (1986). Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women. European Journal of Cancer and Clinical Oncology. 22(6). 716–716. 16 indexed citations

16.

Lipton, Allan, et al.. (1982). Adjuvant antiplatelet therapy with aspirin in colo-rectal cancer.. PubMed. 13(5-6). 419–29. 27 indexed citations

17.

Santen, Richard J., et al.. (1979). Predictive value of progesterone receptor (PgR) in the treatment of metastatic breast cancer with aminoglutethimide. 63(7). 1 indexed citations

18.

Kane, Robert C., H Harvey, Tracy Andrews, et al.. (1979). Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.. PubMed. 63(2). 307–9. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact